Biolectron Inc.

NanoTox[R] Continues to Attract Dynamic Leaders with Addition of La Jolla Capital Partners CEO, C. Richard Piazza, to Board of Directors.
Clinical Trials Week; 4/13/2009; 1111 words; ...directors of its parent company Nano Risk Assessment, Inc. Mr. Piazza is founder and CEO of private equity firm...its Phase II trials. Mr. Piazza also was president of Biolectron, Inc., an internationally renowned private high-tech orthopedic...

Electrical stimulation fails to speed stress fracture healing.(Sports Medicine)
Family Practice News; 1/15/2008; 942 words; ...patients with grades 3 and 4 tibial stress fractures in the placebo group. The researchers had no financial conflicts to disclose, but the Ortho-Pak devices used in the study were supplied by Biolectron Inc. BY HEIDI SPLETE Senior Writer

Chemokine Therapeutics announces addition to senior management team.
PR Newswire; 3/22/2007; 1256 words; ...He has served in numerous CEO positions including MAXIA Pharmaceuticals, VitaGen Inc., Marquest, Smith & Nephew SoloPak, Stimetics and Biolectron. With experience that includes all sectors or healthcare (pharmaceuticals, biotechnology...

Viscogliosi Bros., LLC Appoints Donald Guthner to Manage New Clinical Advisory Unit.
PR Newswire; 4/29/2004; 849 words; ...helped advance Synvisc(R) at Biomatrix, Inc in Ridgefield, NJ, (now Genzyme, Inc.), and was the Director of Clinical & Regulatory Affairs at Biolectron, Inc. when its SpinalPak(R) bone growth stimulator...

Pittsburgh Life Sciences Greenhouse Negotiating with PA Early Stage to Manage up to $20 Million in Initial Pre-Seed Funding.
PR Newswire; 3/18/2003; 1239 words; ...merged with Phoenix International, Inc. Mr. Schmitt joined DNX as that...Before that, he was President of Biolectron, Inc. Prior to that, he gained several...managerial career in 1974 at Nabisco, Inc. He is Chairman of the Board of...